108 related articles for article (PubMed ID: 9468577)
1. RB protein status and chemosensitivity in non-small cell lung cancers.
Yamamoto Y; Shimizu E; Masuda N; Takada M; Sone S
Oncol Rep; 1998; 5(2):447-51. PubMed ID: 9468577
[TBL] [Abstract][Full Text] [Related]
2. Differing effects of staurosporine and UCN-01 on RB protein phosphorylation and expression of lung cancer cell lines.
Shimizu E; Zhao MR; Nakanishi H; Yamamoto A; Yoshida S; Takada M; Ogura T; Sone S
Oncology; 1996; 53(6):494-504. PubMed ID: 8960146
[TBL] [Abstract][Full Text] [Related]
3. Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines.
Kelley MJ; Nakagawa K; Steinberg SM; Mulshine JL; Kamb A; Johnson BE
J Natl Cancer Inst; 1995 May; 87(10):756-61. PubMed ID: 7563154
[TBL] [Abstract][Full Text] [Related]
4. RB activity alters checkpoint response and chemosensitivity in lung cancer lines.
Reed MF; Zagorski WA; Knudsen ES
J Surg Res; 2007 Oct; 142(2):364-72. PubMed ID: 17640669
[TBL] [Abstract][Full Text] [Related]
5. p53 Gene status in relation to ex vivo chemosensitivity of non-small cell lung cancer.
Vogt U; Zaczek A; Klinke F; Granetzny A; Bielawski K; Falkiewicz B
J Cancer Res Clin Oncol; 2002 Mar; 128(3):141-7. PubMed ID: 11935300
[TBL] [Abstract][Full Text] [Related]
6. Differential expressions of cyclin A and the retinoblastoma gene product in histological subtypes of lung cancer cell lines.
Shimizu E; Zhao M; Shinohara A; Namikawa O; Ogura T; Masuda N; Takada M; Fukuoka M; Sone S
J Cancer Res Clin Oncol; 1997; 123(10):533-8. PubMed ID: 9393586
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines.
Shapiro GI; Edwards CD; Kobzik L; Godleski J; Richards W; Sugarbaker DJ; Rollins BJ
Cancer Res; 1995 Feb; 55(3):505-9. PubMed ID: 7834618
[TBL] [Abstract][Full Text] [Related]
8. RB status as a determinant of response to UCN-01 in non-small cell lung carcinoma.
Mack PC; Gandara DR; Bowen C; Edelman MJ; Paglieroni T; Schnier JB; Gelmann EP; Gumerlock PH
Clin Cancer Res; 1999 Sep; 5(9):2596-604. PubMed ID: 10499638
[TBL] [Abstract][Full Text] [Related]
9. Chemoresistance in non-small-cell lung cancer: can multidrug resistance markers predict the response of xenograft lung cancer models to chemotherapy?
Merk J; Rolff J; Dorn C; Leschber G; Fichtner I
Eur J Cardiothorac Surg; 2011 Jul; 40(1):e29-33. PubMed ID: 21420313
[TBL] [Abstract][Full Text] [Related]
10. The soybean-derived peptide lunasin inhibits non-small cell lung cancer cell proliferation by suppressing phosphorylation of the retinoblastoma protein.
McConnell EJ; Devapatla B; Yaddanapudi K; Davis KR
Oncotarget; 2015 Mar; 6(7):4649-62. PubMed ID: 25609198
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer Cells.
Ko JC; Syu JJ; Chen JC; Wang TJ; Chang PY; Chen CY; Jian YT; Jian YJ; Lin YW
Basic Clin Pharmacol Toxicol; 2015 Dec; 117(6):383-91. PubMed ID: 26046675
[TBL] [Abstract][Full Text] [Related]
12. MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells.
Zarogoulidis P; Petanidis S; Kioseoglou E; Domvri K; Anestakis D; Zarogoulidis K
Cell Signal; 2015 Aug; 27(8):1576-88. PubMed ID: 25917317
[TBL] [Abstract][Full Text] [Related]
13. Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations.
Tsai CM; Chang KT; Perng RP; Mitsudomi T; Chen MH; Kadoyama C; Gazdar AF
J Natl Cancer Inst; 1993 Jun; 85(11):897-901. PubMed ID: 8098377
[TBL] [Abstract][Full Text] [Related]
14. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
[TBL] [Abstract][Full Text] [Related]
15. Expression of multidrug resistance proteins and accumulation of cisplatin in human non-small cell lung cancer cells.
Ikuta K; Takemura K; Sasaki K; Kihara M; Nishimura M; Ueda N; Naito S; Lee E; Shimizu E; Yamauchi A
Biol Pharm Bull; 2005 Apr; 28(4):707-12. PubMed ID: 15802814
[TBL] [Abstract][Full Text] [Related]
16. Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines.
Shapiro GI; Park JE; Edwards CD; Mao L; Merlo A; Sidransky D; Ewen ME; Rollins BJ
Cancer Res; 1995 Dec; 55(24):6200-9. PubMed ID: 8521414
[TBL] [Abstract][Full Text] [Related]
17. Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells.
Smith PJ; Souès S; Gottlieb T; Falk SJ; Watson JV; Osborne RJ; Bleehen NM
Br J Cancer; 1994 Nov; 70(5):914-21. PubMed ID: 7947097
[TBL] [Abstract][Full Text] [Related]
18. MRP is frequently expressed in human lung-cancer cell lines, in non-small-cell lung cancer and in normal lungs.
Giaccone G; van Ark-Otte J; Rubio GJ; Gazdar AF; Broxterman HJ; Dingemans AM; Flens MJ; Scheper RJ; Pinedo HM
Int J Cancer; 1996 Jun; 66(6):760-7. PubMed ID: 8647646
[TBL] [Abstract][Full Text] [Related]
19. Non-small and small cell lung carcinoma cell lines exhibit cell type-specific sensitivity to edelfosine-induced cell death and different cell line-specific responses to edelfosine treatment.
Shafer SH; Williams CL
Int J Oncol; 2003 Aug; 23(2):389-400. PubMed ID: 12851688
[TBL] [Abstract][Full Text] [Related]
20. Lactate-induced MRP1 expression contributes to metabolism-based etoposide resistance in non-small cell lung cancer cells.
Dong Q; Zhou C; Ren H; Zhang Z; Cheng F; Xiong Z; Chen C; Yang J; Gao J; Zhang Y; Xu L; Fang J; Cao Y; Wei H; Wu Z
Cell Commun Signal; 2020 Oct; 18(1):167. PubMed ID: 33097055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
